Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Transitional Cell × Electrocardiography × 90 days × Clear all

Sponsor

Conditions

Lymphoma, Non-Hodgkin 2 Carcinoma in Situ 2 Vulvar Neoplasms 1 Vulvar Diseases 1 Uterine Cervical Neoplasms 1 Uterine Cervical Dysplasia 1 Urinary Bladder Neoplasms 1 Triple Negative Breast Neoplasms 1 Recurrence 1 Rectal Neoplasms 1 Papillomavirus Infections 1 Oropharyngeal Neoplasms 1 Myeloproliferative Disorders 1 Myelodysplastic Syndromes 1 Lymphoma, T-Cell, Peripheral 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, Follicular 1 Lymphoma 1 Hematologic Neoplasms 1 Hematologic Diseases 1 Breast Neoplasms 1 Bone Marrow Diseases 1 Anus Neoplasms 1

Interventions

pembrolizumab 22 enfortumab vedotin 14 Magnetic Resonance Spectroscopy 10 Specimen Handling 9 Nivolumab 9 Gemcitabine 9 avelumab 8 Cisplatin 8 atezolizumab 7 Carboplatin 7 sacituzumab govitecan 5 Docetaxel 5 Ipilimumab 4 durvalumab 3 Paclitaxel 3 lenvatinib 2 erdafitinib 2 dodecyl maltoside 2 cabozantinib 2 Taxes 2 Mitomycin 2 Immunoglobulin G 2 Fluorodeoxyglucose F18 2 CTLA-4 Antigen 2 Biopsy 2 ALT-803 2 zimberelimab 1 zanidatamab 1 toripalimab 1 tocilizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡